This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Chugai Seiyaku Kabushiki Kaisha, F. Hoffmann-La Roche Ag. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 987 
1 out of 181 
Years Active: 2015
Title: Tomoaki Ohta: Innovator in Pharmaceutical Composition
Introduction
Tomoaki Ohta is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on oseltamivir phosphate.
Latest Patents
Ohta holds a patent for a pharmaceutical composition comprising oseltamivir phosphate. This invention provides a formulation that includes one or more excipients selected from sugars and sugar alcohols, which maintain an equilibrium water content of 1% by weight or less at 25°C and 70% relative humidity. Additionally, the composition ensures that the amount of glucose and mannose impurities in the sugars and sugar alcohols is 0.01% by weight or less.
Career Highlights
Throughout his career, Ohta has worked with prominent companies in the pharmaceutical industry. He has been associated with F. Hoffmann-La Roche AG and Chugai Seiyaku Kabushiki Kaisha, where he has contributed to various projects and advancements in drug formulation.
Collaborations
Ohta has collaborated with esteemed colleagues, including Hans-Guenter Kaestle and Tomoaki Hirayama. Their combined expertise has furthered the development of innovative pharmaceutical solutions.
Conclusion
Tomoaki Ohta's contributions to pharmaceutical compositions highlight his role as a key innovator in the industry. His work on oseltamivir phosphate demonstrates the importance of research and development in creating effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile